![The sights of Avalon Air Show 2025: Day Three [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/03/f-35-avalon-final-day-scaled-e1743079275404.jpg?#)
Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR
The FDA has approved Soleno Therapeutics' Vykat XR as the first treatment for insatiable hunger related to the rare genetic condition Prader-Willi Syndrome.
The FDA has approved Soleno Therapeutics' Vykat XR as the first treatment for insatiable hunger related to the rare genetic condition Prader-Willi Syndrome.
